Denali Therapeutics
DNLI
#4067
Rank
โ‚ฌ2.77 B
Marketcap
17,36ย โ‚ฌ
Share price
4.18%
Change (1 day)
24.85%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2026 (TTM): -2,44ย โ‚ฌ

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -2,53ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -2,65ย โ‚ฌ a decrease over its 2024 EPS that were of -2,29ย โ‚ฌ.

EPS history for Denali Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,44ย โ‚ฌ-7.79%
2025-2,65ย โ‚ฌ15.56%
2024-2,29ย โ‚ฌ147.12%
2023-0,93ย โ‚ฌ-60%
2022-2,32ย โ‚ฌ8.79%
2021-2,13ย โ‚ฌ-712.82%
20200,35ย โ‚ฌ-118.93%
2019-1,84ย โ‚ฌ402.44%
2018-0,37ย โ‚ฌ-88.89%
2017-3,29ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Organovo
ONVO
-10,28ย โ‚ฌ 305.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-6,34ย โ‚ฌ 150.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-1,36ย โ‚ฌ-46.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-1,16ย โ‚ฌ-54.23% Jersey